نتایج جستجو برای: gp iibiiia inhibitor

تعداد نتایج: 228902  

Journal: :The Journal of general virology 2000
S Y Chan M C Ma M A Goldsmith

Human infection by Marburg (MBG) or Ebola (EBO) virus is associated with fatal haemorrhagic fevers. While these filoviruses may both incite disease as a result of explosive virus replication, we hypothesized that expression of individual viral gene products, such as the envelope glycoprotein (GP), may directly alter target cells and contribute to pathogenesis. We found that expression of EBO GP...

Journal: :BMC Urology 2005
Joachim B Schnier Kayoko Nishi Paul H Gumerlock Frederic A Gorin E Morton Bradbury

BACKGROUND Androgen withdrawal in normal prostate or androgen-dependent prostate cancer is associated with the downregulation of several glycolytic enzymes and with reduced glucose uptake. Although glycogen metabolism is known to regulate the intracellular glucose level its involvement in androgen response has not been studied. METHODS We investigated the effects of androgen on glycogen phosp...

2009
Su-Nam Kim Nam Hyun Kim Woojung Lee Dong-Wan Seo Yong Kee Kim

Although histone deacetylase (HDAC) inhibitors are appreciated as a promising class of anticancer drugs, recent reports show that P-glycoprotein (P-gp) is induced by HDAC inhibitor treatment in cancer cells, resulting in multidrug resistance of cancer cells to other chemotherapeutic agents. In this study, we investigated the molecular mechanism of HDAC inhibitor induction of P-gp expression. HD...

Journal: :International journal of oncology 2010
Jacqueline V Chapman Valérie Gouazé-Andersson Myles C Cabot

The role of glucosylceramide synthase (GCS) in regulating ceramide-induced apoptosis has been widely studied. The purpose of this investigation was to evaluate the role of P-glycoprotein (P-gp) in regulating ceramide cytotoxicity by using C6-ceramide. To accomplish this, we employed HeLa cells with conditional expression of the multidrug resistance gene 1/P-gp. HeLa cells expressing P-gp (P-gp/...

Journal: :Advanced pharmaceutical bulletin 2016
Mehran Mesgari Abbasi Hadi Valizadeh Hamed Hamishekar Leila Mohammadnejad Parvin Zakeri-Milani

PURPOSE P-glycoprotein (P-gp) plays a major role in oral absorption of drugs. Induction or inhibition of P-gp by drugs contributes to variability of its transport activity and often results in clinically relevant drug-drug interactions. The purpose of this study was to investigate the effect of cetirizine, a second generation H1 antihistamine, on P-gp function and expression in vitro and in sit...

Journal: :Journal of immunology 2001
M H Frank M D Denton S I Alexander S J Khoury M H Sayegh D M Briscoe

MDR1 P-glycoprotein (P-gp), the multidrug resistance-associated transmembrane transporter, is physiologically expressed by human peripheral immune cells, but its role in cell-mediated immunity remains poorly understood. Here, we demonstrate a novel role for P-gp in alloantigen-dependent human T cell activation. The pharmacologic P-gp inhibitor tamoxifen (1-10 microM) and the MDR1 P-gp-specific ...

2015
Ezarul Faradianna Lokman Harvest F. Gu Wan Nazaimoon Wan Mohamud Claes-Göran Östenson

Aims. To evaluate the antidiabetic effects of Gynostemma pentaphyllum (GP) in Goto-Kakizaki (GK) rat, an animal model of type 2 diabetes, and to investigate the mechanisms of insulin release. Methods. Oral glucose tolerance test was performed and plasma insulin levels were measured. Results. An oral treatment with GP (0.3 g/kg of body weight daily) for two weeks in GK rats improved glucose tole...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2003
Chi-Yuan Wu Leslie Z Benet

The disposition of tacrolimus and the influence of cyclosporine, troleandomycin, and GF120918 (GG918, or N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamine) on its hepatic disposition were examined in the isolated perfused rat liver. Livers from groups of rats were perfused in a recirculatory manner following a bolus dos...

Journal: :Journal of the American College of Cardiology 2002
Robert J Applegate Mark A Grabarczyk William C Little Timothy Craven Michael Walkup Frederic R Kahl Gregory A Braden Kevin M Rankin Michael A Kutcher

OBJECTIVES The study assessed clinical outcomes of closure device use following percutaneous coronary revascularization using current standards of anticoagulation and antiplatelet therapy. BACKGROUND Evaluation of the outcomes of patients by use of vascular closure devices during coronary interventions employing current standards of anticoagulation and glycoprotein (GP) IIb/IIIa inhibitor the...

Journal: :The Journal of pharmacology and experimental therapeutics 2006
Peng Hsiao Lucy Sasongko Jeanne M Link David A Mankoff Mark Muzi Ann C Collier Jashvant D Unadkat

To predict the magnitude of P-glycoprotein (P-gp)-based drug interactions at the human blood-brain barrier (BBB), rodent studies are routinely conducted where P-gp is chemically inhibited. For such studies to be predictive of interactions at the human BBB, the plasma concentration of the P-gp inhibitor must be comparable with that observed in the clinic. Therefore, we determined the in vivo EC(...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید